Zacks Small Cap Research on MSN6h
AEMD: Patient Enrollments in Oncology Trial Expected to Accelerate With 3rd Participating Site, Protocol AmendmentsAEMD READ THE FULL AEMD RESEARCH REPORT Patient treatments begin in AEMD’s basket oncology trial, enrollments expected to accelerate Aethlon Medical (NASDAQ:AEMD) reported FY 3Q results yesterday and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback